Bonato, M.; Favero, E.; Savoia, F.; Drigo, M.; Rizzato, S.; Orzes, E.; Senna, G.; Romagnoli, M.
Determinants of Clinical Remission in Dupilumab-Treated Severe Eosinophilic Asthma: A Real-World Retrospective Study. Biomedicines 2025, 13, 2404.
https://doi.org/10.3390/biomedicines13102404
AMA Style
Bonato M, Favero E, Savoia F, Drigo M, Rizzato S, Orzes E, Senna G, Romagnoli M.
Determinants of Clinical Remission in Dupilumab-Treated Severe Eosinophilic Asthma: A Real-World Retrospective Study. Biomedicines. 2025; 13(10):2404.
https://doi.org/10.3390/biomedicines13102404
Chicago/Turabian Style
Bonato, Matteo, Elisabetta Favero, Francesca Savoia, Matteo Drigo, Simone Rizzato, Enrico Orzes, Gianenrico Senna, and Micaela Romagnoli.
2025. "Determinants of Clinical Remission in Dupilumab-Treated Severe Eosinophilic Asthma: A Real-World Retrospective Study" Biomedicines 13, no. 10: 2404.
https://doi.org/10.3390/biomedicines13102404
APA Style
Bonato, M., Favero, E., Savoia, F., Drigo, M., Rizzato, S., Orzes, E., Senna, G., & Romagnoli, M.
(2025). Determinants of Clinical Remission in Dupilumab-Treated Severe Eosinophilic Asthma: A Real-World Retrospective Study. Biomedicines, 13(10), 2404.
https://doi.org/10.3390/biomedicines13102404